Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Change Agents Q3 2026 Results: Net Loss of $3.63M, Loss Widens

Change Agents Corporation reported a net loss of $10.29 million for the nine months ended September 30, 2026, compared to a loss of $16.19 million in the prior year period. The company's balance sheet shows a significant reduction in total liabilities from $14.17 million at year-end 2025 to $6.62 million, primarily due to the settlement of liabilities related to discontinued operations.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Profit before tax-3.6-0.1
Net income-3.6-0.3
EPS (diluted, $ a share)$-3.53$-1.25

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, NASDAQ: CHGA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Change Agents Corporation.: key numbers

Share price
$0.8863Close, Nov 16
Market cap
$17.7M
Shares outstanding
19.95MLatest SEC cover page
Sector
Technology
Industry
Services-Computer Programming ServicesSIC 7371

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Change Agents Corporation.

All →
5:10 PM ET 8-K
Leadership Change

Change Agents Leadership Change

Change Agents Corporation appointed Luisa Ingargiola, the company's current Chief Strategy Officer, as its principal executive officer effective November 4, 2026. She will serve in this role until a new Chief Executive Officer is appointed and will not receive additional compensation for the service. The company also issued a $250,000 promissory note to Harllon Holdings LLC and issued 150,000 shares to consultants for services rendered.

4:06 PM ET 8-K
Capital Raise

Change Agents Capital Raise

Change Agents Corporation held a special meeting where stockholders approved several proposals related to equity financing, including the potential issuance of shares under an Equity Purchase Agreement with Hudson Global Ventures, LLC. Stockholders also approved the issuance of shares upon the conversion of promissory notes held by Vanquish Funding Group and an amendment to increase authorized common stock from 100 million to 125 million shares. These approvals were primarily sought to comply with Nasdaq Listing Rule 5635(d) regarding the issuance of 20% or more of outstanding shares.

Counterparty
Hudson Global Ventures, LLC
5:04 PM ET 8-K
Loan & Debt

Change Agents Debt Financing Update with Dune Equity Holdings, LLC

Change Agents Corporation executed unsecured promissory notes totaling $250,000 with maturity dates of December 1, 2026. Additionally, the company entered into waivers with Dune Equity Holdings and FirstFire Global Opportunities Fund regarding prepayment provisions, issuing pre-funded warrants for 99,500 shares as consideration.

Counterparty
Dune Equity Holdings, LLC
Term
through Dec 2026
9:00 AM ET 8-K
Leadership Change

Change Agents Leadership Change

Change Agents Corporation appointed Eric Weisblum as an independent director to its board of directors, effective October 12, 2026. Mr. Weisblum, who is currently the CEO of Silo Pharma Inc, will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees.

8:30 AM ET 8-K
Leadership Change

Change Agents Leadership Change

Meng Li has resigned from her roles as Interim CEO, COO, and Secretary of Change Agents Corporation, effective October 8, 2026. Her departure is intended to facilitate the company's preparation for a potential acquisition in the drone defense industry, and the Board has initiated a search for a replacement from the global defense and AI sectors.

4:15 PM ET 8-K
Loan & Debt

Change Agents Debt Financing Update with certain accredited investors

Change Agents Corporation issued $336,000 in aggregate principal amount of original issue discount promissory notes for gross proceeds of $300,000. The notes mature on April 30, 2027, and the proceeds were used to repay existing indebtedness and for general corporate purposes. As an inducement, the company also issued pre-funded warrants to purchase 100,000 shares of common stock at a nominal exercise price.

Counterparty
certain accredited investors
Term
through April 2027

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.